Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECT: Erlotinib vs Chemotherapy in NSCLC
NCT00989690Phase 3Unknown
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by IRCCS Ospedale San Raffaele. Status: unknown.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00989690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989690.